EUVIMEDEUVIMED entdecken
Crossref

Dark tea-derived exosome-like nanovesicles suppress hepatocellular carcinoma via inhibiting Akt pathway and modulating immune profiles

Yibo Zheng, Shibing Wang, Jiafu Ying, Yuqing Lv, Yuanhao Zhou, Jinzhi You, Weijiao Fan, Xiangming Ye, Guoan Luo, Yuping Chen, Chengwu Zhang, Xiaozhou Mou

Phytomedicine · 2026-09 · 159 · 158548

DOI: 10.1016/j.phymed.2026.158548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Yibo Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rehabilitation Medicine, Rehabilitation and Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine…. Hauptthemen laut MEDLINE: Exosomes, Liver Neoplasms, Proto-Oncogene Proteins c-akt, Carcinoma, Hepatocellular. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Accumulating evidence indicates the microbial fermentation enhanced the health benefits and potential anti-tumor effect of dark tea. However, low bioavailability and unclarified therapeutic mechanisms impeded its deeply application. Plant-derived exosome-like nanoparticles offered a promising option for improving bioavailability and targeted delivery capability. PURPOSE: To obtain dark tea-derived exosome-like nanovesicles (DTELNs) and clarify their material basis, investigate the therapeutic effects on hepatocyte carcinoma (HCC) and potential mechanisms. METHODS: DTELNs were isolated by tangential flow filtration, TEM, NTA, nucleic acid & protein analysis system and LC-MS/MS were used to characterize their morphological characteristics and chemical composition. Orthotopic HCC model mice were established and employed for DTELNs' oral administration. Living imaging, H&E staining and biochemical assays were used to evaluate therapeutic effects. Untargeted metabolomic, 16S rRNA sequencing and cytometry by time-of-flight (CyTOF) were used to investigate the alteration of endogenous substances and immune features. Potential targets were explored by network pharmacology, protein-protein interaction, and verified by western blot. Finally, HCC patient-derived organoids were generated to evaluate the clinical applicability of DTELNs. RESULTS: DTELNs exhibited typical exosomal features, major components including flavonoids, phenolic acids, lipids, amino acids and their derivatives, and miRNAs. DTELNs markedly suppressed tumor proliferation, modulated gut microbial diversity, normalized liver-gut axis physiological homeostasis and enhanced immune responses. DTELNs distinctly downregulated the expressions of p-Akt, NF-κB, Bcl-2, cyclin D1, upregulated the expressions of p-p53, PTEN, Bax, cleaved-caspase 3 and p21. DTELNs also exhibited potent inhibitory effect on HCC organoids. CONCLUSION: DTELNs demonstrated potent therapeutic efficacy against HCC. The mechanisms mainly involved directly modulating Akt-related signalling pathways, rebalancing gut microbiota and related metabolites, and further boosting anti-tumor immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesLiver NeoplasmsProto-Oncogene Proteins c-aktCarcinoma, HepatocellularNanoparticlesTeaAntineoplastic Agents, PhytogenicAnimalsHumansMiceSignal TransductionMale

Stichwörter der Autor:innen

Akt pathwayHepatocellular carcinomaImmune modulationLiver-gut axisPatient-derived organoidsPlant-derived exosome-like nanovesicles

Substanzen

Proto-Oncogene Proteins c-aktTeaAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Center for Rehabilitation Medicine, Rehabilitation and Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine Clinical Research Institute, Zhejiang Provincial People's Hospital, A…
  • Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, China.
  • Translational Medicine Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
  • State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, 999078, China.
  • State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, 999078, China. Electronic address: luoga@tsinghua.edu.cn.
  • General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Z…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zheng, Y., Wang, S., Ying, J., Lv, Y., Zhou, Y., You, J., Fan, W., Ye, X., Luo, G., Chen, Y., Zhang, C., & Mou, X. (2026). Dark tea-derived exosome-like nanovesicles suppress hepatocellular carcinoma via inhibiting Akt pathway and modulating immune profiles. Phytomedicine, 159, 158548. https://doi.org/10.1016/j.phymed.2026.158548

Vancouver

Zheng Y, Wang S, Ying J, Lv Y, Zhou Y, You J, et al. Dark tea-derived exosome-like nanovesicles suppress hepatocellular carcinoma via inhibiting Akt pathway and modulating immune profiles. Phytomedicine. 2026;159:158548. doi:10.1016/j.phymed.2026.158548

BibTeX
@article{Zheng2026,
  author = {Zheng, Yibo and Wang, Shibing and Ying, Jiafu and Lv, Yuqing and Zhou, Yuanhao and You, Jinzhi and Fan, Weijiao and Ye, Xiangming and Luo, Guoan and Chen, Yuping and Zhang, Chengwu and Mou, Xiaozhou},
  title = {Dark tea-derived exosome-like nanovesicles suppress hepatocellular carcinoma via inhibiting Akt pathway and modulating immune profiles},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158548},
  doi = {10.1016/j.phymed.2026.158548}
}
Kostenlos starten →